Silicon Laboratories (NASDAQ:SLAB – Get Free Report) updated its fourth quarter 2024 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of -0.210–0.010 for the period, compared to the consensus estimate of 0.090. The company issued revenue guidance of $161.0 million-$171.0 million, compared to the consensus revenue estimate of $186.9 million. Silicon Laboratories also updated its Q4 guidance to ($0.21)-($0.01) EPS.
Wall Street Analyst Weigh In
A number of research firms have recently weighed in on SLAB. JPMorgan Chase & Co. cut their price target on Silicon Laboratories from $150.00 to $135.00 and set an “overweight” rating for the company in a research note on Tuesday. KeyCorp cut their price target on Silicon Laboratories from $150.00 to $115.00 and set an “overweight” rating for the company in a research note on Tuesday. Needham & Company LLC reaffirmed a “buy” rating and set a $150.00 price target on shares of Silicon Laboratories in a research note on Thursday, July 25th. Benchmark reissued a “hold” rating on shares of Silicon Laboratories in a research note on Tuesday. Finally, Barclays cut their price objective on Silicon Laboratories from $120.00 to $75.00 and set an “equal weight” rating on the stock in a research note on Tuesday. One analyst has rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $125.00.
Read Our Latest Stock Report on SLAB
Silicon Laboratories Stock Performance
Silicon Laboratories (NASDAQ:SLAB – Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The semiconductor company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.20) by $0.07. Silicon Laboratories had a negative return on equity of 9.13% and a negative net margin of 36.53%. The company had revenue of $166.00 million for the quarter, compared to analyst estimates of $165.50 million. During the same quarter last year, the firm earned $0.48 EPS. Silicon Laboratories’s revenue for the quarter was down 18.5% compared to the same quarter last year. On average, research analysts forecast that Silicon Laboratories will post -3.41 earnings per share for the current fiscal year.
Insider Transactions at Silicon Laboratories
In related news, SVP Brandon Tolany sold 845 shares of the business’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $115.00, for a total value of $97,175.00. Following the sale, the senior vice president now owns 43,615 shares of the company’s stock, valued at $5,015,725. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.72% of the stock is owned by insiders.
Silicon Laboratories Company Profile
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
See Also
- Five stocks we like better than Silicon Laboratories
- Dividend Payout Ratio Calculator
- Insider Buying Signals Upside for These 3 Stocks
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- NXP Semiconductors Nears Rock Bottom: A Buy Signal Is Expected
Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.